Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition

Journal of Cellular Physiology

Volumn 229, Issue 12, 2014, Pages 1908-1917

  Cheng, Runfen ^a   Sun, Baocun ^a,b   Liu, Zhiyong ^a   Zhao, Xiulan ^a   Qi, Lisha ^a   Li, Yixian ^a   Gu, Qiang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b The Key Lab of Tianjin Cancer Prevention and Treatment   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM; CALCIUM ION; MYC PROTEIN; PROTEIN BAX; TUMOR MARKER; UVOMORULIN; VIMENTIN; WNT5A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CARCINOGENICITY; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL FEATURE; COHORT ANALYSIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84903622908     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24566     Document Type: Article

References (33)

1. Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, Ten Hagen TL, Kuipers EJ, van Veelen W, Smits R. 2013. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Carcinogenesis 34:2629-2638.
2. Bates RC, Mercurio AM. 2005. The epithelialmesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4:365-370.
3. Berridge MJ, Lipp P, Bootman MD. 2000. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1:11-21.
4. Cha S-W, Tadjuidje E, White J, Wells J, Mayhew C, Wylie C, Heasman J. 2009. Wnt11/5a complex formation caused by tyrosine sulfation increases canonical signaling activity. Curr Biol 19:1573-1580.
5. Clevers H. 2006. Wnt/β-catenin signaling in development and disease. Cell 127:469-480.
6. Defossez P-A, Walker F, Zhang H-H, Odorizzi A, Burgess AW. 2011. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE 6:e22733.
7. Dejmek J. 2005. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65:9142-9146.
8. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT. 2007. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282:17259-17271.
9. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson ME. 2008. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133:462-474.
10. Gavert N, Ben-Ze'ev A. 2008. Epithelialmesenchymal transition and the invasive potential of tumors. Trends Mol Med 14:199-209.
11. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
12. Jessen JR. 2009. Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish 6:21-28.
13. Jin Z, Zhao C, Han X, Han Y. 2012. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression. BMC Cancer 12:480.
14. Leandersson K, Riesbeck K, Andersson T. 2006. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res 34:3988-3999.
15. Liang H, Coles AH, Zhu Z, Zayas J, Jurecic R, Kang J, Jones SN. 2007. Noncanonical Wnt signaling promotes apoptosis in thymocyte development. J Exp Med 204:3077-3084.
16. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN. 2003. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4:349-360.
17. MacLeod RJ, Hayes M, Pacheco I. 2007. Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293:G403-G411.
18. Nishita M, Enomoto M, Yamagata K, Minami Y. 2010. Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol 20:346-354.
19. Olofsson MH, Havelka AM, Brnjic S, Shoshan MC, Linder S. 2008. Charting calcium-regulated apoptosis pathways using chemical biology: Role of calmodulin kinase II. BMC Chem Biol 8:2.
20. Pukrop T. 2006. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci 103:5454-5459.
21. Qi L, Sun B, Liu Z, Li H, Gao J, Leng X. 2012. Dickkopf-1 inhibits epithelialmesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci 103:828-835.
22. Ren D, Minami Y, Nishita M. 2011. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelialmesenchymal transition. Genes Cells 16:304-315.
23. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434:843-850.
24. Rijkers GT, Justement LB, Griffioen AW, Cambier JC. 1990. Improved method for measuring intracellular Ca++ with fluo-3. Cytometry 11:923-927.
25. Ripka S, Konig A, Buchholz M, Wagner M, Sipos B, Kloppel G, Downward J, Gress T, Michl P. 2007. WNT5A target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28:1178-1187.
26. Sipos F. 2012. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. World J Gastroenterol 18:601.
27. Toland AE, Pourreyron C, Reilly L, Proby C, Panteleyev A, Fleming C, McLean K, South AP, Foerster J. 2012. Wnt5a Is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed. PLoS ONE 7:e31827.
28. Wang J, Wu J, Hong J, Chen R, Xu K, Niu W, Peng C, Liu E, Liu S, Agrez M, Niu J. 2011. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6. Cancer Lett 311:38-47.
29. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. 2002. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279-288.
30. Yamamoto H, Kitadai Y, Oue N, Ohdan H, Yasui W, Kikuchi A. 2009. Laminin γ2 mediates Wnt5a-Induced invasion of gastric cancer cells. Gastroenterology 137:242-252.e6.
31. Yamamoto H, Oue N, Sato A, Hasegawa Y, Matsubara A, Yasui W, Kikuchi A. 2010. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29:2036-2046.
32. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, Cha SY, Ryu JK, Choi YJ, Kim J, Fearon ER, Weiss SJ. 2006. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8:1398-1406.
33. Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW, Jung JS. 2007. Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257:172-181.